U.S. Markets closed

PAREXEL's Acquisition by Pamplona Approved by Shareholders

Zacks Equity Research
WF vs. BEN: Which Stock Is the Better Value Option?

PAREXEL International Corporation PRXL is again in the news following the receipt of shareholders’ approval for the impending sell-off of the company to certain investment funds associated with Pamplona Capital Management. The transaction is expected to be completed by Sep 29 following which the company will turn into a privately-held organization

Per the terms of this approximately $5-billion worth deal, Pamplona is slated to acquire all of PAREXEL’s outstanding shares for $88.10 a share in cash. According to the company, the offer price by Pamplona was attractively placed at a premium of 27.9% to the stock’s price just before the market speculation of the news which took place on May 5. Hence 98% of shareholders’ votes were casted in favor of the deal. Notably, the company received the acquisition approval after a shareholders meeting held on Sep 15.

PARAXEL also seems to be upbeat about this sell-off. Per management, the deal will help the company solidify its footprint to exploit opportunities in the pharmaceutical and healthcare spaces.

This leading biopharmaceutical services provider delivered encouraging performance in fiscal 2017. Moreover, the company has an attractive track record of growing organically as well as through acquisitions. In this regard, the company recently introduced a new end-to-end service offering intended to deliver real-world data insights to aid life science companies in enhancing product value demonstration under its PARAXEL Access unit.

PARAXEL operates in a highly fragmented medical services space with the presence of certain well-established players like Medpace Holdings, Inc. MEDP, BioTelemetry, Inc. BEAT and CareDx, Inc. CDNA.

4 Stocks to Watch after the Massive Equifax Hack

Cybersecurity stocks spiked on recent news of a data breach affecting 143 million Americans. But which stocks are the best buy candidates right now? And what does the future hold for the cybersecurity industry?

Equifax is just the most recent victim. Computer hacking and identity theft are more common than ever. Zacks has just released Cybersecurity! An Investor’s Guide to inform Zacks.com readers about this $170 billion/year space. More importantly, it highlights 4 cybersecurity picks with strong profit potential.

Get the new Investing Guide now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BioTelemetry, Inc. (BEAT) : Free Stock Analysis Report
 
PAREXEL International Corporation (PRXL) : Free Stock Analysis Report
 
CareDx, Inc. (CDNA) : Free Stock Analysis Report
 
Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research